Dr. Lal Pathlabs Q4 Results Live : profit rise by 49.17% YOY
₹10.12, marking a significant increase of 48.47% year-over-year, reflecting positively on the company's profitability and shareholder value. Despite the positive financial results, Dr.
Lal Pathlabs has delivered negative returns in the last 1 week, last 6 months, and year-to-date, which might be a point of concern for investors. Currently, the company has a market capitalization of ₹18569.41 Cr with a 52-week high/low of ₹2767.1 & ₹1888.1 respectively, indicating the stock's price volatility over the past year.
Analysts covering the company have mixed recommendations, with a consensus recommendation to Hold the stock as of 12 May, 2024. It's essential for investors to consider these analyst ratings along with the financial performance before making investment decisions.FAQsQuestion : What is the Q4 profit/Loss as per company?Ans : ₹84.5CrQuestion : What is Q4 revenue?Ans : ₹545.4Cr Stay updated on quarterly results with our results calendarMilestone Alert!
Livemint tops charts as the fastest growing news website in the world
